Alessandra Marano

Dr. Alessandra Marano

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2018 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
GSGiuseppe Spinoglio
Giuseppe Spinoglio
PBPaolo P. Bianchi
Paolo P. Bianchi
AMAlessandra Marano
Alessandra Marano
FPFabio Priora
Fabio Priora
LLLuca M. Lenti
Luca M. Lenti
Emilio BertaniEmilio Bertani
Emilio Bertani

1 January 2013 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
AMAlessandra Marano
Alessandra Marano
YCYoon Young Choi
Yoon Young Choi
WHWoo Jin Hyung
Woo Jin Hyung
YKYoo Min Kim
Yoo Min Kim
JKJieun Kim
Jieun Kim
SNSung Hoon Noh
Sung Hoon Noh
Marano A, et al. J Gastric Cancer. 2013 Sep;13(3):136-148. http://dx.doi.org/10.5230/jgc.2013.13.3.136

1 January 2017 in World Journal of Gastroenterology
Verified
Journal Article
Open access
APAmilcare Parisi
Amilcare Parisi
DRDaniel Reim
Daniel Reim
FBFelice Borghi
Felice Borghi
NNNinh T Nguyen
Ninh T Nguyen
FQFeng Qi
Feng Qi
JDJacopo Desiderio
Jacopo Desiderio
Minimally invasive surgery for gastric cancer: A comparison between robotic, laparoscopic and open surgery

4 May 2013 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
AMAlessandra Marano
Alessandra Marano
FPFabio Priora
Fabio Priora
LLLuca Matteo Lenti
Luca Matteo Lenti
FRFerruccio Ravazzoni
Ferruccio Ravazzoni
RQRaoul Quarati
Raoul Quarati
GSGiuseppe Spinoglio
Giuseppe Spinoglio

1 January 2016 in Open Medicine
Verified
Journal Article
Open access
PDF file
AFAlessia Ferrarese
Alessia Ferrarese
GPGiada Pozzi
Giada Pozzi
FBFelice Borghi
Felice Borghi
AMAlessandra Marano
Alessandra Marano
PDPaola Delbon
Paola Delbon
Emanuele CapassoEmanuele Capasso
Emanuele Capasso
Robotic surgery (RS) technology has undergone rapid growth in the surgical field since its approval. In clinical practice, failure of robotic procedures mainly results from a surgeon’s inability or to a device malfunction. We reviewed the literature to estimate the impact of this second circumstance in RS and its consequent legal implications. According to data from the literature, device malfunction is rare. We believe it is necessary to complement surgical training with a technical understanding of RS devices.

24 May 2022 in The Lancet Global Health
Verified
Journal Article
Open access
CSCatherine A Shaw
Catherine A Shaw
RPRiinu Pius
Riinu Pius
TDThomas M Drake
Thomas M Drake
LNLisa Norman
Lisa Norman
AAAdesoji O Ademuyiwa
Adesoji O Ademuyiwa
JLJean Wilguens Lartigue
Jean Wilguens Lartigue
Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide. A multimethods analysis was performed as part of the GlobalSurg 3 study—a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital. Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3·85 [95% CI 2·58–5·75]; p<0·0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63·0% vs 82·7%; OR 0·35 [0·23–0·53]; p<0·0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer. Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised. National Institute for Health and Care Research.